INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 10, 2012 | $10,000 | Replaced |
| 3rd Quarter - Amendment | Aug 22, 2013 | $10,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. Potential prescription drug track-and-trace legislation. RxTEC National Average Drug Acuisition Cost (NADAC) implementation. Calculation and Process National Average Retail Price (NARP) implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JIM DRISCOLL | — |
| MARK EUGENE KINNEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.